Impact of nuclear fragmentation on the stopping power ratio of <sup>12</sup>C ion beams
<i>Objective</i>: Nuclear fragmentation generates a diverse dosimetric environment in the path of<sup>12</sup>C ion beams. Concise parametrization of the beam's composition is paramount for determining key correction factors in clinical dosimetry. This study sets out to provide such a parametrization based on detailed Monte Carlo simulations of clinically relevant<sup>12</sup>C beams. Special attention was paid to the products of nuclear fragmentations and their importance in determining the stopping power ratios.<i>Approach</i>: Using the Monte Carlo simulation package GATE, the spectral fluence of all primary and secondary particles in water were computed at different depths for selected clinically relevant incident energies. Collision-stopping power data was taken from the ICRU90, SRIM and MSTAR database, as well as from previous publications.<i>Main results</i>: The choice of stopping power data was shown to have a bigger impact on the resulting stopping power ratio than the choice of physics lists for the simulations.<i>Significance</i>: A comprehensive analysis of the relationship between fragmentation and dosimetric data has been provided. This study compared different methods for determining spectral fluence-based stopping power ratios, which is essential for accurate ion beam dosimetry.
Authors
- B Poppe (ORCID: https://orcid.org/0009-0006-5901-4775)
- Kilian‐Simon Baumann (ORCID: https://orcid.org/0000-0003-1223-523X)
- Jessica Stolzenberg
- Pascal Saße
- Hui Khee Looe (ORCID: https://orcid.org/0000-0001-5346-9409)
Institutions
- Carl von Ossietzky Universität Oldenburg (DE)
- Universitätsklinikum Gießen und Marburg (DE)
- Institute of Environmental Protection (PL)
Publication Details
- Journal
- Physics in Medicine and Biology
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1088/1361-6560/ad9a36
- Citations
- 1
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Deutsche Forschungsgemeinschaft